Back to User profile » Prof. Dr. Puyuan Xing
Papers published by Prof. Dr. Puyuan Xing:
Bevacizumab Combined with Continuation of EGFR-TKIs in NSCLC Beyond Gradual Progression
Xu Z, Teng F, Hao X, Li J, Xing P
Cancer Management and Research 2022, 14:1891-1902
Published Date: 4 June 2022
Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in EGFR-Mutated Lung Adenocarcinoma: A Real-World Study in Chinese Patients
Xu Z, Hao X, Wang Q, Wang J, Yang K, Wang S, Teng F, Li J, Xing P
Cancer Management and Research 2022, 14:863-873
Published Date: 1 March 2022
Changes and Influential Factors of Chemotherapy Usage for Non-Small Cell Lung Cancer Patients in China: A Multicenter 10-Year (2005–2014) Retrospective Study
Xing PY, Wang SZ, Shi JF, Wang L, Hui ZG, Ren JS, Liu SM, Qiao YL, Dai M, Li JL
Cancer Management and Research 2020, 12:6033-6044
Published Date: 20 July 2020
Real-World Data Of Osimertinib In Patients With Pretreated Non-Small Cell Lung Cancer: A Retrospective Study
Mu Y, Xing P, Hao X, Wang Y, Li J
Cancer Management and Research 2019, 11:9243-9251
Published Date: 30 October 2019